• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用扩散加权磁共振成像的表观扩散系数对可切除性结直肠癌肝转移进行预后预测。

Prognostic prediction of resectable colorectal liver metastasis using the apparent diffusion coefficient from diffusion-weighted magnetic resonance imaging.

作者信息

Yoshikawa Masato, Morine Yuji, Yamada Shinichiro, Miyazaki Katsuki, Tokuda Kazunori, Saito Yu, Arakawa Yusuke, Ikemoto Tetsuya, Imura Satoru, Shimada Mitsuo

机构信息

Department of Surgery Institute of Biomedical Sciences University of Tokushima Tokushima Japan.

出版信息

Ann Gastroenterol Surg. 2020 Oct 5;5(2):252-258. doi: 10.1002/ags3.12404. eCollection 2021 Mar.

DOI:10.1002/ags3.12404
PMID:33860146
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8034686/
Abstract

AIM

Diffusion-weighted magnetic resonance imaging (DWI-MRI) is used to predict tumor malignancy. Here we explored the role of apparent diffusion coefficient (ADC) values in the treatment of patients with resectable colorectal liver metastasis (CRLM).

METHODS

Magnetic resonance imaging (MRI) scans were conducted using a Signa HDe or Signa Explorer 1.5-T scanner (GE Healthcare). ADC maps were calculated using DWI with values of 0, 20, and 800 s/mm. We enrolled 60 patients who underwent upfront hepatic resection for CRLM and divided them into ADC-high (n = 30) and ADC-low (n = 30) groups. Clinicopathological variables of the groups were compared. Immunohistochemical analysis of HIF-1α expression in tumor tissues was performed, and the relationship between the ADC value and HIF-1α expression was evaluated.

RESULTS

The disease-free survival rate of the ADC-low group was significantly lower than that of the ADC-high group ( < .05). Univariate analysis revealed that tumor number (more than five), synchronous metastasis, and low ADC were prognostic factors. Multivariate analysis identified low ADC as an independent prognostic factor. Furthermore, the ADC-low group more frequently expressed high levels of HIF-1α than the ADC-high group.

CONCLUSION

Low ADC values were an independent prognostic factor of resectable CRLM and correlated with HIF-1α expression.

摘要

目的

弥散加权磁共振成像(DWI-MRI)用于预测肿瘤恶性程度。在此,我们探讨了表观扩散系数(ADC)值在可切除性结直肠癌肝转移(CRLM)患者治疗中的作用。

方法

使用Signa HDe或Signa Explorer 1.5-T扫描仪(GE医疗)进行磁共振成像(MRI)扫描。使用DWI并设置值为0、20和800 s/mm来计算ADC图。我们纳入了60例行CRLM初次肝切除的患者,并将他们分为ADC高组(n = 30)和ADC低组(n = 30)。比较两组的临床病理变量。对肿瘤组织中HIF-1α表达进行免疫组化分析,并评估ADC值与HIF-1α表达之间的关系。

结果

ADC低组的无病生存率显著低于ADC高组(P <.05)。单因素分析显示,肿瘤数量(超过5个)、同时性转移和低ADC是预后因素。多因素分析确定低ADC是独立的预后因素。此外,ADC低组比ADC高组更频繁地高表达HIF-1α。

结论

低ADC值是可切除性CRLM的独立预后因素,且与HIF-1α表达相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/242cf2689413/AGS3-5-252-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/37a426bda719/AGS3-5-252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/b21b0e1e94da/AGS3-5-252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/568f614322e2/AGS3-5-252-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/242cf2689413/AGS3-5-252-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/37a426bda719/AGS3-5-252-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/b21b0e1e94da/AGS3-5-252-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/568f614322e2/AGS3-5-252-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aaad/8034686/242cf2689413/AGS3-5-252-g005.jpg

相似文献

1
Prognostic prediction of resectable colorectal liver metastasis using the apparent diffusion coefficient from diffusion-weighted magnetic resonance imaging.利用扩散加权磁共振成像的表观扩散系数对可切除性结直肠癌肝转移进行预后预测。
Ann Gastroenterol Surg. 2020 Oct 5;5(2):252-258. doi: 10.1002/ags3.12404. eCollection 2021 Mar.
2
Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.弥散加权 MRI 表观弥散系数对肿块型肝内胆管细胞癌的预后预测价值。
J Hepatobiliary Pancreat Sci. 2020 Jul;27(7):388-395. doi: 10.1002/jhbp.732. Epub 2020 Apr 6.
3
Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.治疗前扩散加权磁共振成像对接受90Y微球放射性栓塞治疗的结直肠癌肝转移患者预后预测的价值
J Cancer Res Clin Oncol. 2017 Aug;143(8):1531-1541. doi: 10.1007/s00432-017-2395-5. Epub 2017 Mar 19.
4
Correlations between ADC values and molecular markers of Ki-67 and HIF-1α in hepatocellular carcinoma.肝细胞癌中表观扩散系数(ADC)值与Ki-67和缺氧诱导因子-1α(HIF-1α)分子标志物之间的相关性
Eur J Radiol. 2015 Dec;84(12):2464-9. doi: 10.1016/j.ejrad.2015.09.013. Epub 2015 Sep 21.
5
Whole-tumor histogram analysis of diffusion-weighted imaging and dynamic contrast-enhanced MRI for soft tissue sarcoma: correlation with HIF-1alpha expression.软组织肉瘤弥散加权成像和动态对比增强 MRI 的全肿瘤直方图分析:与 HIF-1α表达的相关性。
Eur Radiol. 2023 Jun;33(6):3961-3973. doi: 10.1007/s00330-022-09296-z. Epub 2022 Dec 3.
6
Evaluation of malignancy in gallbladder tumors using the apparent diffusion coefficient obtained by diffusion‑weighted MRI.利用扩散加权磁共振成像获得的表观扩散系数评估胆囊肿瘤的恶性程度。
Oncol Lett. 2024 Sep 4;28(5):533. doi: 10.3892/ol.2024.14666. eCollection 2024 Nov.
7
Impact of apparent diffusion coefficient on prognosis of early hepatocellular carcinoma: a case control study.表观扩散系数对早期肝细胞癌预后的影响:一项病例对照研究。
BMC Surg. 2023 Jan 11;23(1):6. doi: 10.1186/s12893-022-01892-6.
8
Correlations between DWI, IVIM, and HIF-1α expression based on MRI and pathology in a murine model of rhabdomyosarcoma.基于磁共振成像和病理学的鼠横纹肌肉瘤模型中 DWI、IVIM 和 HIF-1α 表达的相关性。
Magn Reson Med. 2022 Aug;88(2):871-879. doi: 10.1002/mrm.29250. Epub 2022 Apr 4.
9
MRI In rectal cancer: Correlations between MRI features and molecular markers Ki-67, HIF-1α, and VEGF.直肠癌的磁共振成像:磁共振成像特征与分子标志物Ki-67、缺氧诱导因子-1α和血管内皮生长因子之间的相关性
J Magn Reson Imaging. 2016 Sep;44(3):594-600. doi: 10.1002/jmri.25195. Epub 2016 Feb 26.
10
Apparent diffusion coefficients in prostate cancer: correlation with molecular markers Ki-67, HIF-1α and VEGF.前列腺癌中的表观扩散系数:与分子标志物Ki-67、HIF-1α和VEGF的相关性
NMR Biomed. 2018 Mar;31(3). doi: 10.1002/nbm.3884. Epub 2018 Jan 9.

引用本文的文献

1
The relationship between the tumor microenvironment of hepatocellular carcinoma - including cancer-associated fibroblasts and tumor-associated macrophages - and apparent diffusion coefficient.肝细胞癌的肿瘤微环境(包括癌症相关成纤维细胞和肿瘤相关巨噬细胞)与表观扩散系数之间的关系。
Am J Cancer Res. 2025 Apr 15;15(4):1747-1758. doi: 10.62347/ZGGJ9531. eCollection 2025.
2
Alteration of Apparent Diffusion Coefficient Measurements Predict Survival Outcomes During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.表观扩散系数测量值的改变可预测局部晚期直肠癌新辅助放化疗期间的生存结果。
In Vivo. 2025 Mar-Apr;39(2):927-935. doi: 10.21873/invivo.13897.

本文引用的文献

1
Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study.结直肠癌肝转移中 KRAS 突变与扩散加权成像的关系:初步研究。
Eur J Radiol. 2020 Apr;125:108895. doi: 10.1016/j.ejrad.2020.108895. Epub 2020 Feb 25.
2
Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases.基线 3D-ADC 比 2D-ADC 更能预测结直肠癌肝转移患者对治疗的反应。
Eur Radiol. 2020 Jan;30(1):291-300. doi: 10.1007/s00330-019-06289-3. Epub 2019 Jun 17.
3
Apparent diffusion coefficients in prostate cancer: correlation with molecular markers Ki-67, HIF-1α and VEGF.
前列腺癌中的表观扩散系数:与分子标志物Ki-67、HIF-1α和VEGF的相关性
NMR Biomed. 2018 Mar;31(3). doi: 10.1002/nbm.3884. Epub 2018 Jan 9.
4
Prediction of the histopathologic findings of intrahepatic cholangiocarcinoma: qualitative and quantitative assessment of diffusion-weighted imaging.肝内胆管癌的组织病理学发现预测:扩散加权成像的定性和定量评估。
Eur Radiol. 2018 May;28(5):2047-2057. doi: 10.1007/s00330-017-5156-6. Epub 2017 Dec 12.
5
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.泛亚地区转移性结直肠癌管理的 ESMO 共识指南:日本临床肿瘤学会-欧洲肿瘤内科学会、韩国癌症学会、中国临床肿瘤学会、韩国肿瘤学会和日本肿瘤外科学会共同支持的一项 JSMO-ESMO 倡议。
Ann Oncol. 2018 Jan 1;29(1):44-70. doi: 10.1093/annonc/mdx738.
6
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.日本结直肠癌学会(JSCCR)2016年结直肠癌治疗指南。
Int J Clin Oncol. 2018 Feb;23(1):1-34. doi: 10.1007/s10147-017-1101-6. Epub 2017 Mar 27.
7
Apparent diffusion coefficient value for estimating clinicohistological factors in bladder cancer including infiltration style and lymphatic invasion.用于评估膀胱癌临床组织学因素(包括浸润方式和淋巴浸润)的表观扩散系数值。
Springerplus. 2016 Jun 23;5(1):848. doi: 10.1186/s40064-016-2504-y. eCollection 2016.
8
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.ESMO 共识指南:转移性结直肠癌患者的管理。
Ann Oncol. 2016 Aug;27(8):1386-422. doi: 10.1093/annonc/mdw235. Epub 2016 Jul 5.
9
Prediction of low-risk breast cancer using perfusion parameters and apparent diffusion coefficient.利用灌注参数和表观扩散系数预测低风险乳腺癌
Magn Reson Imaging. 2016 Feb;34(2):67-74. doi: 10.1016/j.mri.2015.10.028. Epub 2015 Oct 30.
10
Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.胃癌中表观扩散系数与HER2状态的相关性:初步研究。
BMC Cancer. 2015 Oct 20;15:749. doi: 10.1186/s12885-015-1726-7.